Pleomorphic Adenoma Gene 1 Mediates the Role of Karyopherin Alpha 2 and Has Prognostic Significance in Hepatocellular Carcinoma

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2014 Jul 26

PMID 25060425

Citations 17

Authors

Zhe-Yuan Hu

Sheng-Xian Yuan

Yuan Yang

Wei-Ping Zhou

Hua Jiang

Affiliations

Soon will be listed here.

Abstract

Background: Karyopherin alpha 2 (KPNA2) promotes tumor growth in hepatocellular carcinoma (HCC). We aimed to determine the content and clinical significance of mechanism underlying.

Methods: The association of transcriptional factor pleomorphic adenoma gene 1 (PLAG1) with KPNA2 was explored by co-immunoprecipitation. In vitro gain- and loss-of-function models were established to explore the functional interaction. Clinical samples from 314 HCC patients were applied to explore the clinical significance.

Results: We found that PLAG1 could associate with KPNA2 and be promoted into nucleus by KPNA2. The increment of proliferative and metastatic abilities by KPNA2 over-expression can be significantly retarded by PLAG1 inhibition. The co-enrichment of KPNA2 and PLAG1 in nucleus is observed in clinical samples and can distinguish patients with the worst prognosis. The positive PLAG1 expression is an independent risk factor of recurrence free survival (HR: 1.766, 1.315-2.371; P = 0.000) and overall survival (HR: 1.589, 1.138-2.220; P = 0.007). Especially for patients with positive KPNA2 staining (N = 152), the positive PLAG1 expression is the sole risk factor for both recurrence free survival (HR: 1.749, 1.146-2.670; P = 0.010) and overall survival (HR: 1.662, 1.007-2.744; P = 0.047).

Conclusions: The nuclear import of PLAG1 by KPNA2 is essential for the role of KPNA2 in HCC cells and is significant to predict poor survival of HCC patients after hepatectomy.

Citing Articles

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

Qin H, Han Y, Li J, Wu Q, Du Y, Li Q NPJ Precis Oncol. 2025; 9(1):65.

PMID: 40057617 PMC: 11890584. DOI: 10.1038/s41698-025-00840-w.

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer.

Deng Y, Yang X, Hua H, Zhang C Int J Gen Med. 2022; 15:6485-6497.

PMID: 35966504 PMC: 9365118. DOI: 10.2147/IJGM.S370576.

Overexpression of Karyopherin α2 in small cell carcinoma of the cervix correlates with poor prognosis.

Liao L, Gu Z, Fang M, Yao G, Huang L Int J Clin Exp Pathol. 2022; 15(6):241-246.

PMID: 35795090 PMC: 9253809.

HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.

Chen T, Liu R, Niu Y, Mo H, Wang H, Lu Y Cell Death Dis. 2021; 12(12):1152.

PMID: 34903711 PMC: 8668937. DOI: 10.1038/s41419-021-04449-2.

Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.

Zhang J, Zhang X, Wang L, Kang C, Li N, Xiao Z PeerJ. 2021; 9:e12197.

PMID: 34616632 PMC: 8462373. DOI: 10.7717/peerj.12197.

References

Kau T, Way J, Silver P . Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer. 2004; 4(2):106-17. DOI: 10.1038/nrc1274. View

Forner A, Llovet J, Bruix J . Hepatocellular carcinoma. Lancet. 2012; 379(9822):1245-55. DOI: 10.1016/S0140-6736(11)61347-0. View

Fan M, Huang C, Gu Y, Xiao Y, Sheng J, Zhong L . Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. J Exp Clin Cancer Res. 2013; 32(1):21. PMC: 3699415. DOI: 10.1186/1756-9966-32-21. View

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

Wang Y, Dong Y, Wang W, Xie X, Wang Z, Chen R . Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J Exp Clin Cancer Res. 2013; 32(1):51. PMC: 3751285. DOI: 10.1186/1756-9966-32-51. View

Van Dyck F, Declercq J, Braem C, Van de Ven W . PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review). Int J Oncol. 2007; 30(4):765-74. View

Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang D, Sole M . IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol. 2010; 52(4):550-9. PMC: 3662876. DOI: 10.1016/j.jhep.2010.01.015. View

Altan B, Yokobori T, Mochiki E, Ohno T, Ogata K, Ogawa A . Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis. 2013; 34(10):2314-21. DOI: 10.1093/carcin/bgt214. View

Patz M, Pallasch C, Wendtner C . Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs. Leuk Lymphoma. 2010; 51(8):1379-81. DOI: 10.3109/10428194.2010.496016. View

10.

Jiang J, Sliva D . Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. Int J Oncol. 2010; 37(6):1529-36. DOI: 10.3892/ijo_00000806. View

11.

van der Watt P, Ngarande E, Leaner V . Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity. PLoS One. 2011; 6(11):e27723. PMC: 3220698. DOI: 10.1371/journal.pone.0027723. View

12.

Krawczyk E, Hanover J, Schlegel R, Suprynowicz F . Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. Biochem Biophys Res Commun. 2008; 371(4):684-8. PMC: 2773212. DOI: 10.1016/j.bbrc.2008.04.122. View

13.

Braem C, Kas K, Meyen E, Debiec-Rychter M, Van de Ven W, Voz M . Identification of a karyopherin alpha 2 recognition site in PLAG1, which functions as a nuclear localization signal. J Biol Chem. 2002; 277(22):19673-8. DOI: 10.1074/jbc.M112112200. View

14.

Huang L, Wang H, Li J, Wang J, Zhou Y, Luo R . KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Cell Death Dis. 2013; 4:e745. PMC: 3763430. DOI: 10.1038/cddis.2013.256. View

15.

Matsuyama A, Hisaoka M, Hashimoto H . PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study. Virchows Arch. 2011; 459(5):539-45. DOI: 10.1007/s00428-011-1149-z. View

16.

Conti E, Muller C, Stewart M . Karyopherin flexibility in nucleocytoplasmic transport. Curr Opin Struct Biol. 2006; 16(2):237-44. DOI: 10.1016/j.sbi.2006.03.010. View

17.

Yoshitake K, Tanaka S, Mogushi K, Aihara A, Murakata A, Matsumura S . Importin-α1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol. 2011; 18(7):2093-103. DOI: 10.1245/s10434-011-1569-7. View

18.

Li C, Ji L, Ding Z, Zhang Q, Huang G . Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma. Tumour Biol. 2013; 34(2):1021-6. DOI: 10.1007/s13277-012-0641-7. View

19.

Huang G, Lai E, Lau W, Zhou W, Shen F, Pan Z . Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg. 2012; 257(3):490-505. DOI: 10.1097/SLA.0b013e318262b218. View

20.

Christiansen A, Dyrskjot L . The functional role of the novel biomarker karyopherin α 2 (KPNA2) in cancer. Cancer Lett. 2012; 331(1):18-23. PMC: 7126488. DOI: 10.1016/j.canlet.2012.12.013. View